Clinical Trials Directory

Trials / Completed

CompletedNCT02209675

Role of Tissue C4d in Differentiation Between Acut e Rejection and HCV Recurrence After Liver Transplantation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Assessment of the role of tissue C4d complement fragments in liver biopsy as a new marker for differentiating between acute rejection and Hepatitis C (HCV) recurrence in recipients post living donor liver transplantation (LDLT) .As each condition require different treatment

Detailed description

Role of tissue c4d assessment by immunohistchemistry in liver biopsy in differentiation between recurrent hepatitis c and rejection after liver transplantation.pathological examination may be sometimes confusing between the rejection and recurrent hepatitis C

Conditions

Interventions

TypeNameDescription
OTHERliver biopsyC4d assessment by immunohistchemistry in liver biopsy

Timeline

Start date
2012-12-01
Primary completion
2014-06-01
Completion
2014-10-01
First posted
2014-08-06
Last updated
2014-10-15

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02209675. Inclusion in this directory is not an endorsement.